(Q44228279)

English

Liquid chromatography-mass spectrometry method for the analysis of the anti-cancer agent capecitabine and its nucleoside metabolites in human plasma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Liquid chromatography-mass spectrometry method for the analysis of the anti-cancer agent capecitabine and its nucleoside metabolites in human plasma (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

author name string

Yan Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jean L Grem

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

783

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

273-285

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900674-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900674-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900674-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900674-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900674-8

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900674-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900674-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900674-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1570-0232(02)00674-8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44228279&oldid=2108754813"